You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Positron-Emission Tomography

Showing 51 - 75 of 9,003
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Tumor Trial in Los Angeles (device, drug, other, procedure)

Active, not recruiting
  • Prostate Neoplasm
  • CAT
  • +5 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 19, 2022

Prostate Carcinoma Trial in Duarte (procedure, other, device)

Recruiting
  • Prostate Carcinoma
  • Computed Tomography
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

An Imaging Agent With Positron Emission Tomography/Magnetic

Recruiting
  • Recurrent Soft Tissue Sarcoma
  • +2 more
  • Fluorodopa F 18
  • +4 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 4, 2023

Malignant Ovarian Tumor, Ovarian Carcinoma Trial in Houston (Dynamic Enhanced CT, Magnetic Resonance Imaging, Positron Emission

Recruiting
  • Malignant Ovarian Neoplasm
  • Ovarian Carcinoma
  • Dynamic Enhanced CT
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Brain Glioblastoma Trial in Houston (Computed Tomography, Fludeoxyglucose F-18, Magnetic Resonance Imaging)

Completed
  • Brain Glioblastoma
  • Computed Tomography
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8 Trial (drug, procedure,

Not yet recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +3 more
  • (no location specified)
Oct 21, 2023

Sickle Cell Disease Trial (Positron Emission Tomography, Cu-64]-LLP2A)

Recruiting
  • Sickle Cell Disease
  • Pittsburgh, Pennsylvania
    UPMC
Dec 2, 2022

Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Los Angeles (procedure, drug, other)

Not yet recruiting
  • Recurrent Multiple Myeloma
  • Refractory Multiple Myeloma
  • Bone Marrow Aspiration
  • +10 more
  • Los Angeles, California
    Melanie Ayala Ceja
Jul 10, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • San Francisco, California
    University of California San Francisco
Dec 19, 2022

Bladder Urothelial Carcinoma, Urothelial Carcinoma Trial in Philadelphia (Copper Cu 64 TP3805, Positron Emission Tomography,

Active, not recruiting
  • Bladder Urothelial Carcinoma
  • Urothelial Carcinoma
  • Copper Cu 64 TP3805
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Dec 13, 2022

Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Rochester (procedure, drug, biological)

Not yet recruiting
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Biopsy
  • +10 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 9, 2023

Metastatic Malignant Solid Tumor Trial in Duarte (procedure, radiation, drug)

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • Lymphoma
  • Positron Emission Tomography
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Nov 18, 2022

Castration Resistant Prostate Cancer, Castration Sensitive Prostate Cancer Trial in Portland (drug, procedure, other)

Not yet recruiting
  • Castration Resistant Prostate Cancer
  • Castration Sensitive Prostate Cancer
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jun 16, 2023

Radiotracer, Hypertension, Cholesterol Trial in Ann Arbor (FNP-59)

Recruiting
  • Radiotracer
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan
Dec 9, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial (radiation, biological, procedure)

Withdrawn
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Copper Cu 64-DOTA-pembrolizumab
  • +2 more
  • (no location specified)
Jun 7, 2022

Breast Cancer, Breast Tumor Trial in Philadelphia ([18F]ISO-1)

Active, not recruiting
  • Breast Cancer
  • Breast Neoplasm
  • Philadelphia, Pennsylvania
    University of Pennsylvania Hospital
Jan 17, 2023

Hematopoietic and Lymphoid System Tumor, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial (BET

Not yet recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • +5 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +6 more
  • (no location specified)
Apr 6, 2023

Recurrent DLBCL, Refractory DLBCL Trial in Houston (Chemotherapy, Computed Tomography, Fludeoxyglucose F-18)

Completed
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2022

Prostate Cancer Trial in Edmonton (PSMA-1007 Positron Emission Tomography (PET) scan and 3T Magnetic Resonance Imaging (MRI))

Recruiting
  • Prostate Cancer
  • PSMA-1007 Positron Emission Tomography (PET) scan and 3T Magnetic Resonance Imaging (MRI)
  • Edmonton, Alberta, Canada
    University of Alberta
Jan 9, 2023

PET/CT Characterization of Treatment Resistance

Recruiting
  • Prostate Cancer
  • F-fluorodeoxyglucose positron emission tomography (FDG PET)
  • prostate-specific membrane antigen positron emission tomography (PSMA PET)
  • Madison, Wisconsin
    University of Wisconsin
Jan 24, 2023

Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Recurrent Trial in Dallas (68Ga-PSMA-11, Positron Emission

Available
  • Prostate Cancer
  • +2 more
  • Dallas, Texas
    UT Southwestern Medical Center
Sep 27, 2022

Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8, Stage IIA Prostate Cancer AJCC v8 Trial in Chicago (procedure,

Not yet recruiting
  • Prostate Adenocarcinoma
  • +3 more
  • Biopsy of Prostate
  • +6 more
  • Chicago, Illinois
    Northwestern University
May 9, 2023

Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6

Not yet recruiting
  • Grade 3b Follicular Lymphoma
  • +5 more
  • Biospecimen Collection
  • +9 more
  • (no location specified)
Jun 6, 2023

Multiple Myeloma, Plasma Cell Myeloma Trial in San Francisco (drug, procedure, other)

Not yet recruiting
  • Multiple Myeloma
  • Plasma Cell Myeloma
  • Zirconium Zr 89-DFO-YS5
  • +3 more
  • San Francisco, California
    University of California, San Francisco
May 26, 2023

Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical

Not yet recruiting
  • Clinical Stage I Esophageal Adenocarcinoma AJCC v8
  • +5 more
  • Biospecimen Collection
  • +9 more
  • Scottsdale, Arizona
  • +2 more
Oct 11, 2023